Abstract:Objective To increase the killing effect of aminolevulinic acid (ALA)-based photodynamic therapy (PDT) on a human skin squamous cell carcinoma cell line A431 by poly lactic-co-glycolic acid nanoparticles (PLGA NPs).Methods ALA-loaded PLGA NPs (ALA PLGA NPs) were prepared using a modified double emulsion solvent evaporation method,and characterized in terms of size,encapsulation efficiency,loading capacity and morphology.Transmission electron microscopy was carried out to observe the morphology of A431 cells after uptake of ALA PLGA NPs.To optimize incubation time,multi-mode microplate reader was used to describe the fluorescence kinetics of protoporphyrin Ⅸ generated by A431 cells during 24 hours of incubation with 0.1 mmol/L ALA,1 mmol/L ALA,2.7 g/L ALA PLGA NPs containing about 0.1 mmol/L ALA,and PLGA NPs without ALA separately.Some A431 cells were divided into 10 groups:control group receiving neither treatment nor irradiation,0.1 and 1 mmol/L ALA dark/PDT group incubated 0.1 and 1 mmol/L ALA respectively,ALA PLGA NP dark/PDT group incubated with ALA PLGA NPs of 2.7 g/L,PLGA NP dark/PDT group incubated with PLGA NPs of 2.7 g/L,simple irradiation group irradiated with a He-Ne laser (wavelength:635 nm,power density:8.6 mW/cm2,energy density:8 J/cm2) only.The dark groups were kept in darkness strictly by wrapping in aluminum foil,and PDT groups were irradiated using a He-Ne laser.After another 24 hours of culture following irradiation,methyl thiazolyl tetrazolium (MTF) assay was conducted to estimate the survival rate of cells.To study the effect of ALA PLGA NPs on cell apoptosis,some A431 cells were divided into three groups:control group receiving neither treatment nor irradiation,ALA-PDT group and ALA PLGA NP PDT group receiving PDT after incubation with ALA and ALA PLGA NPs respectively.Flow cytometry was performed to detect the apoptosis of A431 cells at 12 and 24 hours,separately,after the photodynamic therapy.Data were statistically analyzed using SPSS 13.0 software package by means of a t test.Results The prepared ALA PLGA NPs were spherical with a mean particle size of (65.6 ± 26) nm,encapsulation efficiency of (65.8 ± 7.2) ％,and drug loading capacity of (0.62 ± 0.27)％.ALA PLGA NPs could be uptaken by A431 cells and gathered in the cytoplasm.The PpIX fluorescence kinetic study showed that the fluorescence intensity increased with time within 24 hours in A431 cells incubated with ALA or ALA PLGA NPs.After 6 and 24 hours of incubation,the A431 cells incubated with 2.7 g/L ALA PLGA NPs showed a significant increase in the protoporphyrin Ⅸ fluorescence intensity compared with those incubated with 0.1 mmol/L ALA (both P ＜ 0.01).Further more,the survival rate of A431 cells was statistically lower in the ALA PLGA NP PDT group than in the 0.1 mmol/L ALA PDT group at 6 and 24 hours (t =35.685,5.262,respectively,both P ＜ 0.01).Elevated apoptosis rate was observed in the ALA PLGA NP PDT group compared with the ALA PDT group at 12 ((13.10 ± 0.50)％ vs.(4.90 ± 0.13)％,t =9.074,P＜ 0.01) and 24 ((30.17 ± 1.02)％ vs.(11.6 ± 0.59)％,t =9.095,P ＜ 0.01) hours.Conclusions ALA PLGA NPs can promote the formation of protoporphyrin Ⅸ,strengthen the killing effect of ALA-PDT on A431 cells in vitro,and enhance the apoptosis induced by ALA-PDT in tumor cells.

Inhibition of MAPK Signaling Pathways Enhances Cell Death Induced by 5-Aminolevulinic Acid-Photodynamic Therapy in Skin Squamous Carcinoma Cells

Photodynamic Therapy Activated Stat3 Associated Pathways: Targeting Intrinsic Apoptotic Pathways to Increase Pdt Efficacy in Human Squamous Carcinoma Cells

Mechanisms Underlying the Effect of 5-Aminolevulinic Acid Photodynamic Therapy on Cutaneous Squamous Cell Carcinoma in SKH-1 Mice

Modified 5-Aminolevulinic Acid Photodynamic Therapy (M-PDT) Inhibits Cutaneous Squamous Cell Carcinoma Cell Proliferation Via Targeting PP2A/PP5-mediated MAPK Signaling Pathway.

Microarray Analysis Elucidates Potential Mechanism of 5-Aminolevulinic Acid-Based Photodynamic Therapy in Treating Cutaneous Squamous Cell Carcinoma

5-aminolevulinic acid photodynamic therapy inhibits invasion and metastasis of SCL-1 cells probably via MTSS1 and p63 gene related pathways

5-Aminolevulinic Acid Photodynamic Therapy Enhance the Effect of Acitretin on Squamous Cell Carcinoma Cells: an in Vitro Study

Modified 5-aminolevulinic acid photodynamic therapy suppresses cutaneous squamous cell carcinoma through blocking Akt/mTOR-mediated autophagic flux

Therapeutic and immune effects of 5-aminolevulinic acid photodynamic therapy on UVB-induced squamous cell carcinomas in hairless mice.

Molecular Characterization of Gene Expression Changes in Murine Cutaneous Squamous Cell Carcinoma after 5-Aminolevulinic Acid Photodynamic Therapy.

Treating Cutaneous Squamous Cell Carcinoma Using 5-Aminolevulinic Acid Polylactic-Co-Glycolic Acid Nanoparticle-Mediated Photodynamic Therapy in A Mouse Model

Ala-Pdt Inhibits Proliferation and Promotes Apoptosis of Scc Cells Through Stat3 Signal Pathway

Modified 5‐aminolevulinic Acid Photodynamic Therapy Reduces Pain and Improves Therapeutic Effects in Cutaneous Squamous Cell Carcinoma Mouse Model

PD-L1 Blockade Potentiates the Antitumor Effects of ALA-PDT and Optimizes the Tumor Microenvironment in Cutaneous Squamous Cell Carcinoma

Apoptosis of HL60 Cell Induced by 5-Aminolevulinic Acid-Based Photodynamic Therapy

5-aminolevulinic acid photodynamic therapy inhibits the viability, invasion, and migration of cervical cancer SiHa cells by regulating the miR-152-3p/JAK1/STAT1 axis

Optimization of the Treatment of Squamous Cell Carcinoma Cells by Combining Photodynamic Therapy with Cold Atmospheric Plasma

Modified 5-Aminolevulinic Acid Photodynamic Therapy Induces Cutaneous Squamous Cell Carcinoma Cell Pyroptosis Via the JNK Signaling Pathway.

CCL8 Enhances Sensitivity of Cutaneous Squamous Cell Carcinoma to Photodynamic Therapy by Recruiting M1 Macrophages.

Killing Effect of Aminolevulinic Acid-Loaded Poly Lactic-Co-glycolic Acid Nanoparticle-Based Photodynamic Therapy on a Human Skin Squamous Cell Carcinoma Cell Line A431

Topical Photodynamic Therapy of Squamous Cell Carcinomas in a Hairless Mouse Model